Skip Nav Destination
1-3 of 3
Keywords: mitogen-activated protein kinaseClose
Arantxa Ortega, Ma Teresa Pérez de Prada, Petra J. Mateos-Cáceres, Priscila Ramos Mozo, Juan J. González-Armengol, Juan M. González del Castillo, Javier Martín Sánchez, Pedro Villarroel, José L. Santiago, Ricardo J. Bosch, Carlos Macaya, Pedro Esbrit, Antonio J. López-Farré
Clin Sci (Lond) (2007) 113 (7): 319–327.
Published: 03 September 2007
... C inhibitor, partially decreased the enhancing effect of PTHrP-(1–36) on ADP-induced platelet activation. Meanwhile, 10 −6 mol/l PTHrP-(7–34), a PTH1R antagonist, as well as 10 −5 mol/l PD098059, a MAPK (mitogen-activated protein kinase) inhibitor, or a farnesyltransferase inhibitor abolished...
Etsuko KIBAYASHI, Masaharu URAKAZE, Chikaaki KOBASHI, Mika KISHIDA, Michiyo TAKATA, Akira SATO, Katsuya YAMAZAKI, Masashi KOBAYASHI
Clin Sci (Lond) (2005) 108 (6): 515–521.
Published: 24 May 2005
.... The phosphorylation of MAPKs (mitogen-activated protein kinases) was determined by Western blot. The production of IL-8 induced by CRP (10 μg/ml) was enhanced significantly and was inhibited by pitavastatin. The expression of IL-8 mRNA was increased in a dose-dependent manner after stimulation with CRP (1–100 μg/ml...
Clin Sci (Lond) (2002) 103 (s2002): 137S–140S.
Published: 01 September 2002
... The Biochemical Society and the Medical Research Society 2002 endothelin-1 mitogen-activated protein kinase vascular smooth muscle cell ...